Tesamorelin 10mg

Tesamorelin 10mg Research Peptide

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analogue supplied by Unbothered Peptides strictly for laboratory and scientific research.

Tesamorelin was originally developed as the active ingredient in Egrifta and has been studied in relation to growth hormone signalling, IGF-1 pathways, body composition markers, visceral adipose tissue and broader metabolic research models.

Research Background

Tesamorelin is a stabilised GHRH(1-44) analogue. In research settings, it is studied for its interaction with pituitary GHRH receptors and its role in pulsatile growth hormone signalling and downstream IGF-1 activity.

Mechanism of Action

Tesamorelin binds to GHRH receptors in the pituitary pathway and is studied for its influence on rhythmic growth hormone pulse activity. Its research profile is often discussed in relation to visceral adipose tissue, hepatic fat research models, lipid markers and body composition pathways.

Half-Life & Activity Window

The active fragment has a reported short plasma half-life of approximately 26 minutes, while downstream growth hormone signalling effects may persist beyond the initial peptide activity window in research models.

Product Details

• Product: Tesamorelin
• Size: 10mg
• Format: Lyophilised research peptide
• Use: Research purposes only

Research use only. This product is not intended for human consumption, medical use, veterinary use, diagnosis, treatment, cure or prevention of any disease.